Cathepsin L colocalizes with chromogranin A in chromaffin vesicles to generate active peptides

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3547-3557

  Biswas, Nilima ^a   Rodriguez Flores, Juan L ^a   Courel, Maite ^a   Gayen, Jiaur R ^a   Vaingankar, Sucheta M ^a   Mahata, Manjula ^a   Torpey, Justin W ^b   Taupenot, Laurent ^a   O'Connor, Daniel T ^a,b,c   Mahata, Sushil K ^a,c  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOLAMINE; CATHEPSIN L; CHROMOGRANIN A; GLYCINE; LEUCINE; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; NICOTINE; PROLINE; PROPROTEIN CONVERTASE 1; PROPROTEIN CONVERTASE 2; SERINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE RELEASE; CHROMAFFIN CELL; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALS; CATECHOLAMINES; CATHEPSINS; CELLS, CULTURED; CHROMAFFIN CELLS; CHROMOGRANIN A; CYSTEINE ENDOPEPTIDASES; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; PC12 CELLS; PEPTIDES; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 67651174537     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1613     Document Type: Article

References (63)

1. Winkler H, Fischer-Colbrie R 1992 The chromogranins A and B: the first 25 years and future perspectives. Neuroscience 49:497-528
2. Taupenot L, Harper KL, O'Connor DT 2003 Mechanisms of disease: the chromogranin-secretogranin family. N Engl J Med 348:1134-1149
3. Montero-Hadjadje M, Vaingankar S, Elias S, Tostivint H, Mahata SK, Anouar Y 2008 Chromogranins A and B and secretogranin II: evolutionary and functional aspects. Acta Physiol (Oxf) 192:309-324
4. Takiyyuddin MA, Cervenka JH, Hsiao RJ, Barbosa JA, Parmer RJ, O'Connor DT 1990 Chromogranin A. Storage and release in hypertension. Hypertension 15:237-246
5. Takiyyuddin MA, Cervenka JH, Sullivan PA, Pandian MR, Parmer RJ, Barbosa JA, O'Connor DT 1990 Is physiologic sympathoadrenal catecholamine release exocytotic in humans? Circulation 81:185-195
6. Kelly RB 1985 Pathways of protein secretion in eukaryotes. Science 230:25-32
7. Kim T, Tao-Cheng JH, Eiden LE, Loh YP 2001 Chromogranin A, an "on/off" switch controlling dense-core secretory granule biogenesis. Cell 106:499-509
8. Kim T, Zhang CF, Sun Z, Wu H, Loh YP 2005 Chromogranin A deficiency in transgenic mice leads to aberrant chromaffin granule biogenesis. J Neurosci 25:6958-6961
9. Courel M, Rodemer C, Nguyen ST, Pance A, Jackson AP, O'connor DT, Taupenot L 2006 Secretory granule biogenesis in sympathoadrenal cells: identification of a granulogenic determinant in the secretory prohormone chromogranin A. J Biol Chem 281:38038-38051
10. Tatemoto K, Efendiæ S, Mutt V, Makk G, Feistner GJ, Barchas JD 1986 Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion. Nature 324:476-478
11. Cadman PE, Rao F, Mahata SK, O'Connor DT 2002 Studies of the dysglycemic peptide, pancreastatin, using a human forearm model. Ann NY Acad Sci 971:528-529
12. Aardal S, Helle KB, Elsayed S, Reed RK, Serck-Hanssen G 1993 Vasostatins, comprising the N-terminal domain of chromogranin A, suppress tension in isolated human blood vessel segments. J Neuroendocrinol 5:405-412
13. Mahata SK, O'Connor DT, Mahata M, Yoo SH, Taupenot L, Wu H, Gill BM, Parmer RJ 1997 Novel autocrine feedback control of catecholamine release. A discrete chromogranin A fragment is a noncompetitive nicotinic cholinergic antagonist. J Clin Invest 100:1623-1633
14. 344-364) acts at the receptor to prevent nicotinic cholinergic tolerance. J Biol Chem 274:2920-2928
15. Mahata SK, Mahata M, Wakade AR, O'Connor DT 2000 Primary structure and function of the catecholamine release inhibitory peptide catestatin (chromogranin A344-364): Identification of amino acid residues crucial for activity. Mol Endocrinol 14:1525-1535
16. Mahata SK 2004 Catestatin - the catecholamine release inhibitory peptide: a structural and functional overview. Curr Med Chem Immun Endocr Metab Agents 4:221-234
17. Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA, et al 1995 Chromogranin A in human hypertension. Influence of heredity. Hypertension 26:213-220
18. O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ 2002 Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens 20:1335-1345
19. Mahapatra NR, O'Connor DT, Vaingankar SM, Hikim AP, Mahata M, Ray S, Staite E, Wu H, Gu Y, Dalton N, Kennedy BP, Ziegler MG, Ross J, Mahata SK 2005 Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog. J Clin Invest 115:1942-1952
20. Benjannet S, Leduc R, Adrouche N, Falgueyret JP, Marcinkiewicz M, Seidah NG, Mbikay M, Lazure C, Chretien M 1987 Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues. FEBS Lett 224:142-148
21. Hoflehner J, Eder U, Laslop A, Seidah NG, Fischer-Colbrie R, Winkler H 1995 Processing of secretogranin II by prohormone convertases: importance of PC1 in generation of secretoneurin. FEBS Lett 360:294-298
22. Eskeland NL, Zhou A, Dinh TQ, Wu H, Parmer RJ, Mains RE, O'Connor DT 1996 Chromogranin A processing and secretion: specific role of endogenous and exogenous prohormone convertases in the regulated secretory pathway. J Clin Invest 98:148-156
23. Seidah NG, Day R, Marcinkiewicz M, Chrétien M 1998 Precursor convertases: an evolutionary ancient, cell-specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann NY Acad Sci 839:9-24
24. Laslop A, Weiss C, Savaria D, Eiter C, Tooze SA, Seidah NG, Winkler H 1998 Proteolytic processing of chromogranin B and secretogranin II by prohormone convertases. J Neurochem 70:374-383
25. Seidah NG, Prat A 2002 Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem 38:79-94
26. Doblinger A, Becker A, Seidah NG, Laslop A 2003 Proteolytic processing of chromogranin A by the prohormone convertase PC2. Regul Pept 111:111-116
27. Scamuffa N, Calvo F, Chrétien M, Seidah NG, Khatib AM 2006 Proprotein convertases: lessons from knockouts. FASEB J 20:1954-1963
28. Parmer RJ, Mahata M, Gong Y, Mahata SK, Jiang Q, O'Connor DT, Xi XP, Miles LA 2000 Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion. J Clin Invest 106:907-915
29. Jiang Q, Taupenot L, Mahata SK, Mahata M, O'Connor DT, Miles LA, Parmer RJ 2001 Proteolytic cleavage of chromogranin A (CgA) by plasmin: selective liberation of a specific bioactive CgA fragment that regulates catecholamine release. J Biol Chem 276:25022-25029
30. Biswas N, Vaingankar SM, Mahata M, Das M, Gayen JR, Taupenot L, Torpey JW, O'Connor DT, Mahata SK 2008 Proteolytic cleavage of human chromogranin a containing naturally occurring catestatin variants: differential processing at catestatin region by plasmin. Endocrinology 149:749-757
31. Yasothornsrikul S, Greenbaum D, Medzihradszky KF, Toneff T, Bundey R, Miller R, Schilling B, Petermann I, Dehnert J, Logvinova A, Goldsmith P, Neveu JM, Lane WS, Gibson B, Reinheckel T, Peters C, Bogyo M, Hook V 2003 Cathepsin L in secretory vesicles functions as a prohormone-processing enzyme for production of the enkephalin peptide neurotransmitter. Proc Natl Acad Sci USA 100:9590-9595
32. Hwang SR, Garza C, Mosier C, Toneff T, Wunderlich E, Goldsmith P, Hook V 2007 Cathepsin L expression is directed to secretory vesicles for enkephalin neuropeptide biosynthesis and secretion. J Biol Chem 282:9556-9563
33. Funkelstein L, Toneff T, Hwang SR, Reinheckel T, Peters C, Hook V 2008 Cathepsin L participates in the production of neuropeptide Y in secretory vesicles, demonstrated by protease gene knockout and expression. J Neurochem 106:384-391
34. Hook V, Funkelstein L, Lu D, Bark S, Wegrzyn J, Hwang SR 2008 Proteases for processing proneuropeptides into peptide neurotransmitters and hormones. Annu Rev Pharmacol Toxicol 48:393-423
35. Kirschke H, Barrett AJ, Rawlings ND 1995 Proteinases 1: lysosomal cysteine proteinases. Protein Profile 2:1581-1643
36. Docherty K, Carroll R, Steiner DF 1983 Identification of a 31,500 molecular weight islet cell protease as cathepsin B. Proc Natl Acad Sci USA 80:3245-3249
37. Docherty K, Hutton JC, Steiner DF 1984 Cathepsin B-related proteases in the insulin secretory granule. J Biol Chem 259:6041-6044
38. Kukor Z, Mayerle J, Krüger B, Tóth M, Steed PM, Halangk W, Lerch MM, Sahin-Tóth M 2002 Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. J Biol Chem 277:21389-21396
39. Neves FA, Duncan KG, Baxter JD 1996 Cathepsin B is a prorenin processing enzyme. Hypertension 27:514-517
40. Jutras I, Reudelhuber TL 1999 Prorenin processing by cathepsin B in vitro and in transfected cells. FEBS Lett 443:48-52
41. McCoy K, Gal S, Schwartz RH, Gottesman MM 1988 An acid protease secreted by transformed cells interferes with antigen processing. J Cell Biol 106: 1879-1884
42. Goretzki L, Schmitt M, Mann K, Calvete J, Chucholowski N, Kramer M, Günzler WA, Jänicke F, Graeff H 1992 Effective activation of the proenzyme form of the urokinase-type plasminogen activator (pro-uPA) by the cysteine protease cathepsin L. FEBS Lett 297:112-118
43. Kasai M, Shirasawa T, Kitamura M, Ishido K, Kominami E, Hirokawa K 1993 Proenzyme from of cathepsin L produced by thymic epithelial cells promotes proliferation of immature thymocytes in the presence of IL-1, IL-7, and anti-CD3 antibody. Cell Immunol 150:124-136
44. Stypmann J, Gläser K, Roth W, Tobin DJ, Petermann I, Matthias R, Mönnig G, Haverkamp W, Breithardt G, Schmahl W, Peters C, Reinheckel T 2002 Dilated cardiomyopathy in mice deficient for the lysosomal cysteine peptidase cathepsin L. Proc Natl Acad Sci USA 99:6234-6239
45. Yang M, Zhang Y, Pan J, Sun J, Liu J, Libby P, Sukhova GK, Doria A, Katunuma N, Peroni OD, Guerre-Millo M, Kahn BB, Clement K, Shi GP 2007 Cathepsin L activity controls adipogenesis and glucose tolerance. Nat Cell Biol 9:970-977
46. Li W, Kornmark L, Jonasson L, Forssell C, Yuan XM 2009 Cathepsin L is significantly associated with apoptosis and plaque destabilization in human atherosclerosis. Atherosclerosis 202:92-102
47. Mahata M, Mahata SK, Parmer RJ, O'Connor DT 1996 Vesicular monoamine transport inhibitors. Novel action at calcium channels to prevent catecholamine secretion. Hypertension 28:414-420
48. Taupenot L, Remacle JE, Helle KB, Aunis D, Bader MF 1995 Recombinant human chromogranin A: expression, purification and characterization of the N-terminal derived peptides. Regul Pept 56:71-88
49. Courel M, Vasquez MS, Hook VY, Mahata SK, Taupenot L 2008 Sorting of the neuroendocrine secretory protein secretogranin II into the regulated secretory pathway: role of N- and C-terminal α-helical domains. J Biol Chem 283:11807-11822
50. Brix K, Linke M, Tepel C, Herzog V 2001 Cysteine proteinases mediate extracellular prohormone processing in the thyroid. Biol Chem 382:717-725
51. Colombo B, Longhi R, Marinzi C, Magni F, Cattaneo A, Yoo SH, Curnis F, Corti A 2002 Cleavage of chromogranin A N-terminal domain by plasmin provides a new mechanism for regulating cell adhesion. J Biol Chem 277: 45911-45919
52. Tepel C, Brömme D, Herzog V, Brix K 2000 Cathepsin K in thyroid epithelial cells: sequence, localization and possible function in extracellular proteolysis of thyroglobulin. J Cell Sci 113 Pt 24:4487-4498
53. Metz-Boutigue MH, Garcia-Sablone P, Hogue-Angeletti R, Aunis D 1993 Intracellular and extracellular processing of chromogranin A. Determination of cleavage sites. Eur J Biochem 217:247-257
54. Orr DF, Chen T, Johnsen AH, Chalk R, Buchanan KD, Sloan JM, Rao P, Shaw C 2002 The spectrum of endogenous human chromogranin A-derived peptides identified using a modified proteomic strategy. Proteomics 2:1586-1600
55. Funkelstein L, Toneff T, Mosier C, Hwang SR, Beuschlein F, Lichtenauer UD, Reinheckel T, Peters C, Hook V 2008 Major role of cathepsin L for producing the peptide hormones ACTH, β-endorphin, and α-MSH, illustrated by protease gene knockout and expression. J Biol Chem 283:35652-35659
56. Crooks GE, Hon G, Chandonia JM, Brenner SE 2004 WebLogo: a sequence logo generator. Genome Res 14:1188-1190
57. Yasothornsrikul S, Aaron W, Toneff T, Hook VY 1999 Evidence for the proenkephalin processing enzyme prohormone thiol protease (PTP) as a multicatalytic cysteine protease complex: activation by glutathione localized to secretory vesicles. Biochemistry 38:7421-7430
58. Puzer L, Cotrin SS, Alves MF, Egborge T, Araújo MS, Juliano MA, Juliano L, Brömme D, Carmona AK 2004 Comparative substrate specificity analysis of recombinant human cathepsin V and cathepsin L. Arch Biochem Biophys 430: 274-283
59. Abboud-Jarrous G, Atzmon R, Peretz T, Palermo C, Gadea BB, Joyce JA, Vlodavsky I 2008 Cathepsin L is responsible for processing and activation of proheparanase through multiple cleavages of a linker segment. J Biol Chem 283:18167-18176
60. Beynon RJ, Bond JS 1989 Proteolytic enzymes: a practical approach. New York: IRL Press at Oxford University Press
61. Mahata SK, Mahata M, Wen G, Wong WB, Mahapatra NR, Hamilton BA, O'Connor DT 2004 The catecholamine release-inhibitory "catestatin" fragment of chromogranin A: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. Mol Pharmacol 66:1180-1191
62. Rao F, Wen G, Gayen JR, Das M, Vaingankar SM, Rana BK, Mahata M, Kennedy BP, Salem RM, Stridsberg M, Abel K, Smith DW, Eskin E, Schork NJ, Hamilton BA, Ziegler MG, Mahata SK, O'Connor DT 2007 Catecholamine release-inhibitory peptide catestatin [chromogranin A(352-372)]: naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. Circulation 115:2271-2281
63. Krieger TJ, Hook VY 1991 Purification and characterization of a novel thiol protease involved in processing the enkephalin precursor. J Biol Chem 266: 8376-8383